NASDAQ: GRCEGrace Therapeutics Inc Stock Ownership - Who owns Grace Therapeutics?
Insider buying vs selling
Have Grace Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GRCE insiders and whales buy or sell their stock.
GRCE Shareholders
What type of owners hold Grace Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Grace 2018 Irrevocable Trust Rajitha | 46.25% | 4,689,547 | $13.32M | Insider |
| Aigh Capital Management LLC | 13.04% | 1,322,379 | $3.76M | Institution |
| Nantahala Capital Management LLC | 11.62% | 1,178,203 | $3.35M | Institution |
| Adar1 Capital Management LLC | 9.46% | 959,571 | $2.73M | Insider |
| George Kottayil | 4.88% | 494,698 | $1.40M | Insider |
| Bank Of America Corp | 4.88% | 494,698 | $1.40M | Institution |
| Adar1 Capital Management LLC | 3.39% | 343,512 | $975.57k | Institution |
| William A. Haseltine | 3.28% | 332,836 | $945.25k | Insider |
| Stonepine Capital Management LLC | 2.90% | 294,550 | $836.52k | Institution |
| Vanguard Group Inc | 2.52% | 255,400 | $725.34k | Institution |
GRCE vs Biotech Stocks
Grace Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.